Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2010
08/18/2010CN101284017B A method for continuously preparing birds nest extract with narrow molecular weight distribution by enzymolysis and membrane filtration coupling technique
08/18/2010CN101279032B External use medicament for curing itch
08/18/2010CN101195008B Cattail pollen skin cleaning agent for treating gynecology disease and technique of preparing the same thereof
08/18/2010CN101129475B Extractive of humulus plants, its use and pharmaceutical composition containing the extractive
08/18/2010CN101113130B Method for preparing high-purity hypocrellin A
08/18/2010CN101040971B Chinese traditional medicine compound having functions of anti-acne, hole-complementarity and speckle-eliminating
08/18/2010CN100998640B Medicine for treating burns and scald, and its preparing method
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7776843 water soluble, microparticulates; bone injuries
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2461212C Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals
08/17/2010CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide
08/12/2010WO2010091124A2 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
08/12/2010WO2010091068A2 Treatment of non-oral biological tissue with chlorine dioxide
08/12/2010WO2010091066A2 Chlorine dioxide treatment for biological tissue
08/12/2010WO2010090546A1 Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration
08/12/2010WO2010090502A2 External use composition containing cholecalciferol or its derivative for treating skin disorders
08/12/2010WO2010090001A1 Skin-whitening agent, anti-aging agent, and anti-oxidant agent
08/12/2010WO2010089492A1 Method for coating microspheres onto a flexible material
08/12/2010WO2010088778A1 Cd109 polypeptides and uses thereof for the treatment of skin cells
08/12/2010WO2010056922A3 Systems and methods for delivery of biologically active agents
08/12/2010WO2010033494A3 Compositions, methods, devices, and systems for skin care
08/12/2010US20100204339 Orally Bioavailable Stilbenoids- Compositions and Therapeutic Applications Thereof
08/12/2010US20100204331 Prostaglandin deriative-containing aqueous liquid preparation
08/12/2010US20100204326 Novel agents for treatment of ailments and dysfunctions
08/12/2010US20100204322 Method of treating autoimmune diseases
08/12/2010US20100204320 Pharmaceuticals for xerosis
08/12/2010US20100204317 Methods of treating dermatological disorders or conditions
08/12/2010US20100204262 Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
08/12/2010US20100204256 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
08/12/2010US20100204248 Medicaments and methods for inhibition of non-ocular scarring
08/12/2010US20100204227 Isoindoline compounds and methods of their use
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204191 Function-Selective Vitamin D Receptor Agonist
08/12/2010US20100204175 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
08/12/2010US20100204174 Novel active ingredient in cicatrization and use thereof
08/12/2010US20100204170 Heterobifunctional pan-selectin inhibitors
08/12/2010US20100204162 Substrate reduction therapy
08/12/2010US20100204158 Combination of splenopentin and thymopentin and the use thereof in medicine
08/12/2010US20100204156 Use of thymopentin as a therapeutic agent
08/12/2010US20100204152 Use of gluten exorphin c : as a therapeutic agent
08/12/2010US20100204126 Therapy for melanin related afflictions
08/12/2010US20100204116 Use of calcitonin as anti-angiogenic agent
08/12/2010US20100204115 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents
08/12/2010US20100204114 Use of a galanin peptide as a therapeutic agent
08/12/2010US20100204113 Use of stresscopin-related peptide as a therapeutic agent
08/12/2010US20100204110 Use of a peptide as a therapeutic agent
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203175 DEGLYCATION OF AGEs
08/12/2010US20100203158 Antiseptic compositions and uses thereof
08/12/2010US20100203153 Sustained-release nanoparticle compositions and methods using the same
08/12/2010US20100203135 Skin Equivalent Culture
08/12/2010US20100203107 Methods of Administering a Dermatological Agent to a Subject
08/12/2010US20100203101 Bio-membrane for tissue regeneration
08/12/2010US20100203089 Selective chemokine modulation
08/12/2010US20100203088 Silver Nanoparticle Dispersion Formulation
08/12/2010US20100203064 Methods and compositions for modulating wound repair
08/12/2010US20100203055 Hair regrowth promoter
08/12/2010US20100203052 Binding domain-immunoglobulin fusion proteins
08/12/2010US20100203041 Antibodies to egfl7 and methods for their use
08/12/2010US20100203029 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/12/2010US20100203016 Pregnancy hormone combination for treatment of autoimmune diseases
08/12/2010US20100203005 Transdermal compositions
08/12/2010US20100203001 Process for forming disulfide bridges
08/12/2010US20100202978 Foamable benzoyl peroxide compositions for topical administration
08/12/2010US20100202973 Microrna molecules associated with inflammatory skin disorders
08/12/2010CA2759115A1 Treatment of non-oral biological tissue with chlorine dioxide
08/12/2010CA2759112A1 Chlorine dioxide treatment for biological tissue
08/12/2010CA2751386A1 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
08/12/2010CA2750870A1 Method for coating microspheres onto a flexible material
08/12/2010CA2750469A1 Method and compositions for treating skin
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216319A2 Oligomers of straight-chain and unbranched fatty acids, and medicaments containing the same
08/11/2010EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient
08/11/2010EP2216022A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
08/11/2010EP2215119A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
08/11/2010EP2215089A1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
08/11/2010EP2215059A2 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
08/11/2010EP2214689A2 Cosmetic or dermatological composition containing an orchid extract, and cosmetic care method using said composition
08/11/2010EP2214686A1 Calcium-rich alkaline powder produced from processed molluse shells
08/11/2010EP2214659A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
08/11/2010EP2214634A1 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter
08/11/2010EP2214482A1 Prostaglandin analog compositions and methods to treat epithelial-related conditions
08/11/2010EP1984522B1 Methods of increasing lymphatic function
08/11/2010EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients
08/11/2010EP1438073B1 Polyoxyalkylene conjugates as enzyme inhibitors
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 1065